Global Cancer Immunotherapy Sales Market Report Forecast 2017-2021

September 2017 | 103 pages | ID: GE6AC4004DDEN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 CANCER IMMUNOTHERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Immunotherapy
1.2 Classification of Cancer Immunotherapy
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Cancer Immunotherapy
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Cancer Immunotherapy Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Cancer Immunotherapy (2012-2021)
  1.5.1 Global Cancer Immunotherapy Sales and Growth Rate (2012-2021)
  1.5.2 Global Cancer Immunotherapy Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON CANCER IMMUNOTHERAPY INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 CANCER IMMUNOTHERAPY MANUFACTURING COST ANALYSIS

3.1 Cancer Immunotherapy Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Cancer Immunotherapy

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Cancer Immunotherapy Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL CANCER IMMUNOTHERAPY COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Cancer Immunotherapy Market Competition by Manufacturers
  5.1.1 Global Cancer Immunotherapy Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Cancer Immunotherapy Revenue and Share by Manufacturers (2012-2017)
5.2 Global Cancer Immunotherapy (Volume and Value) by Type
  5.5.1 Global Cancer Immunotherapy Sales and Market Share by Type (2012-2017)
  5.5.2 Global Cancer Immunotherapy Revenue and Market Share by Type (2012-2017)
5.3 Global Cancer Immunotherapy (Volume and Value) by Regions
  5.3.1 Global Cancer Immunotherapy Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Cancer Immunotherapy Revenue and Market Share by Regions (2012-2017)
5.4 Global Cancer Immunotherapy (Volume) by Application

6 UNITED STATES CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

6.1 United States Cancer Immunotherapy Sales and Value (2012-2017)
  6.1.1 United States Cancer Immunotherapy Sales and Growth Rate (2012-2017)
  6.1.2 United States Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
  6.1.3 United States Cancer Immunotherapy Sales Price Trend (2012-2017)
6.2 United States Cancer Immunotherapy Sales and Market Share by Manufacturers
6.3 United States Cancer Immunotherapy Sales and Market Share by Type
6.4 United States Cancer Immunotherapy Sales and Market Share by Application

7 CHINA CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

7.1 China Cancer Immunotherapy Sales and Value (2012-2017)
  7.1.1 China Cancer Immunotherapy Sales and Growth Rate (2012-2017)
  7.1.2 China Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
  7.1.3 China Cancer Immunotherapy Sales Price Trend (2012-2017)
7.2 China Cancer Immunotherapy Sales and Market Share by Manufacturers
7.3 China Cancer Immunotherapy Sales and Market Share by Type
7.4 China Cancer Immunotherapy Sales and Market Share by Application

8 EUROPE CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Cancer Immunotherapy Sales and Value (2012-2017)
  8.1.1 Europe Cancer Immunotherapy Sales and Growth Rate (2012-2017)
  8.1.2 Europe Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Cancer Immunotherapy Sales Price Trend (2012-2017)
8.2 Europe Cancer Immunotherapy Sales and Market Share by Manufacturers
8.3 Europe Cancer Immunotherapy Sales and Market Share by Type
8.4 Europe Cancer Immunotherapy Sales and Market Share by Application

9 JAPAN CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Cancer Immunotherapy Sales and Value (2012-2017)
  9.1.1 Japan Cancer Immunotherapy Sales and Growth Rate (2012-2017)
  9.1.2 Japan Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Cancer Immunotherapy Sales Price Trend (2012-2017)
9.2 Japan Cancer Immunotherapy Sales and Market Share by Manufacturers
9.3 Japan Cancer Immunotherapy Sales and Market Share by Type
9.4 Japan Cancer Immunotherapy Sales and Market Share by Application

10 GLOBAL CANCER IMMUNOTHERAPY MANUFACTURERS ANALYSIS

10.1 Amgen
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 AstraZeneca
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 F. Hoffman La-Roche
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Bayer AG
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Bristol-Myers Squibb
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Eli Lilly and Company
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Janssen Global Services
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Merck
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Novartis
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL CANCER IMMUNOTHERAPY MARKET FORECAST (2017-2021)

13.1 Global Cancer Immunotherapy Sales, Revenue Forecast (2017-2021)
13.2 Global Cancer Immunotherapy Sales Forecast by Regions (2017-2021)
13.3 Global Cancer Immunotherapy Sales Forecast by Type (2017-2021)
13.4 Global Cancer Immunotherapy Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Immunotherapy
Table Classification of Cancer Immunotherapy
Figure Global Sales Market Share of Cancer Immunotherapy by Type in 2015
Table Applications of Cancer Immunotherapy
Figure Global Sales Market Share of Cancer Immunotherapy by Application in 2015
Figure United States Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Figure China Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Figure Europe Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Figure Japan Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Figure Global Cancer Immunotherapy Sales and Growth Rate (2012-2021)
Figure Global Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Table Global Cancer Immunotherapy Sales of Key Manufacturers (2012-2017)
Table Global Cancer Immunotherapy Sales Share by Manufacturers (2012-2017)
Figure 2015 Cancer Immunotherapy Sales Share by Manufacturers
Figure 2016 Cancer Immunotherapy Sales Share by Manufacturers
Table Global Cancer Immunotherapy Revenue by Manufacturers (2012-2017)
Table Global Cancer Immunotherapy Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Cancer Immunotherapy Revenue Share by Manufacturers
Table 2016 Global Cancer Immunotherapy Revenue Share by Manufacturers
Table Global Cancer Immunotherapy Sales and Market Share by Type (2012-2017)
Table Global Cancer Immunotherapy Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Immunotherapy by Type (2012-2017)
Figure Global Cancer Immunotherapy Sales Growth Rate by Type (2012-2017)
Table Global Cancer Immunotherapy Revenue and Market Share by Type (2012-2017)
Table Global Cancer Immunotherapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Immunotherapy by Type (2012-2017)
Figure Global Cancer Immunotherapy Revenue Growth Rate by Type (2012-2017)
Table Global Cancer Immunotherapy Sales and Market Share by Regions (2012-2017)
Table Global Cancer Immunotherapy Sales Share by Regions (2012-2017)
Figure Sales Market Share of Cancer Immunotherapy by Regions (2012-2017)
Figure Global Cancer Immunotherapy Sales Growth Rate by Regions (2012-2017)
Table Global Cancer Immunotherapy Revenue and Market Share by Regions (2012-2017)
Table Global Cancer Immunotherapy Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Cancer Immunotherapy by Regions (2012-2017)
Figure Global Cancer Immunotherapy Revenue Growth Rate by Regions (2012-2017)
Table Global Cancer Immunotherapy Sales and Market Share by Application (2012-2017)
Table Global Cancer Immunotherapy Sales Share by Application (2012-2017)
Figure Sales Market Share of Cancer Immunotherapy by Application (2012-2017)
Figure Global Cancer Immunotherapy Sales Growth Rate by Application (2012-2017)
Figure United States Cancer Immunotherapy Sales and Growth Rate (2012-2017)
Figure United States Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
Figure United States Cancer Immunotherapy Sales Price Trend (2012-2017)
Table United States Cancer Immunotherapy Sales by Manufacturers (2012-2017)
Table United States Cancer Immunotherapy Market Share by Manufacturers (2012-2017)
Table United States Cancer Immunotherapy Sales by Type (2012-2017)
Table United States Cancer Immunotherapy Market Share by Type (2012-2017)
Table United States Cancer Immunotherapy Sales by Application (2012-2017)
Table United States Cancer Immunotherapy Market Share by Application (2012-2017)
Figure China Cancer Immunotherapy Sales and Growth Rate (2012-2017)
Figure China Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
Figure China Cancer Immunotherapy Sales Price Trend (2012-2017)
Table China Cancer Immunotherapy Sales by Manufacturers (2012-2017)
Table China Cancer Immunotherapy Market Share by Manufacturers (2012-2017)
Table China Cancer Immunotherapy Sales by Type (2012-2017)
Table China Cancer Immunotherapy Market Share by Type (2012-2017)
Table China Cancer Immunotherapy Sales by Application (2012-2017)
Table China Cancer Immunotherapy Market Share by Application (2012-2017)
Figure Europe Cancer Immunotherapy Sales and Growth Rate (2012-2017)
Figure Europe Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Europe Cancer Immunotherapy Sales Price Trend (2012-2017)
Table Europe Cancer Immunotherapy Sales by Manufacturers (2012-2017)
Table Europe Cancer Immunotherapy Market Share by Manufacturers (2012-2017)
Table Europe Cancer Immunotherapy Sales by Type (2012-2017)
Table Europe Cancer Immunotherapy Market Share by Type (2012-2017)
Table Europe Cancer Immunotherapy Sales by Application (2012-2017)
Table Europe Cancer Immunotherapy Market Share by Application (2012-2017)
Figure Japan Cancer Immunotherapy Sales and Growth Rate (2012-2017)
Figure Japan Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Japan Cancer Immunotherapy Sales Price Trend (2012-2017)
Table Japan Cancer Immunotherapy Sales by Manufacturers (2012-2017)
Table Japan Cancer Immunotherapy Market Share by Manufacturers (2012-2017)
Table Japan Cancer Immunotherapy Sales by Type (2012-2017)
Table Japan Cancer Immunotherapy Market Share by Type (2012-2017)
Table Japan Cancer Immunotherapy Sales by Application (2012-2017)
Table Japan Cancer Immunotherapy Market Share by Application (2012-2017)
Table Amgen Basic Information List
Table Amgen Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Cancer Immunotherapy Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Cancer Immunotherapy Global Market Share (2012-2017)
Table F. Hoffman La-Roche Basic Information List
Table F. Hoffman La-Roche Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffman La-Roche Cancer Immunotherapy Global Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer AG Cancer Immunotherapy Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Cancer Immunotherapy Global Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly and Company Cancer Immunotherapy Global Market Share (2012-2017)
Table Janssen Global Services Basic Information List
Table Janssen Global Services Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Global Services Cancer Immunotherapy Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Cancer Immunotherapy Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Cancer Immunotherapy Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Immunotherapy
Figure Manufacturing Process Analysis of Cancer Immunotherapy
Figure Cancer Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
Table Major Buyers of Cancer Immunotherapy
Table Distributors/Traders List
Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast (2017-2021)
Figure Global Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Table Global Cancer Immunotherapy Sales Forecast by Regions (2017-2021)
Table Global Cancer Immunotherapy Sales Forecast by Type (2017-2021)
Table Global Cancer Immunotherapy Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis
Pfizer
Seattle Genetics
Peregrine Pharmaceuticals
Viralytics Ltd
Immunomedics